Millions with joint pain and osteoarthritis are missing the most powerful treatment
Stiff knees and aching hips may seem like an inevitable part of aging, but experts say we’re getting osteoarthritis all wrong. Despite affecting nearly 600 million people worldwide - and potentially a billion by 2050 - the most powerful treatment isn’t surgery or medication. It’s exercise. Movement nourishes cartilage, strengthens muscles, reduces inflammation, and even reshapes the biological processes driving joint damage.
Source: ScienceDaily
Clinical Challenges in Managing Shoulder Osteoarthritis and Suprascapular Neuropathy
Chronic shoulder pain is a common and multifactorial condition. Suprascapular nerve neuropathy, although relatively uncommon, may lead to pain, weakness, and muscle atrophy as a result of extrinsic compression, trauma, or inflammation. When it occurs in the presence of glenohumeral osteoarthritis, overall shoulder function may be further compromised, complicating both diagnostic assessment and therapeutic decisionmaking.
Source: Cureus
Matrix-assisted autologous chondrocyte implantation may yield high return to sports rate
Results showed chondral defects of the knee treated with matrix-assisted autologous chondrocyte implantation may yield a high rate of patient satisfaction and return to sports in a community practice.
Source: Healio
Does losing weight make an athlete better? Associations between body composition and performance
In endurance sports such as running and cross-country skiing, a lighter body weight can improve relative power generation and reduce energy consumption. However, losing weight requires an energy deficit, which can negatively impact health and performance. Therefore, weight optimization always involves balancing the benefits and risks. In addition to weight, body composition can also impact an athlete's performance.
Source: Medical Xpress
New technology, cost strategies continue to move robotic-assisted surgery forward
The combination of robotics and patient-specific instrumentation may create a parallel strategy for care. Vendor programs and care pathways may curb the cost of robotic-assisted surgery.
Source: Healio
